Urinary neutrophil gelatinase-associated lipocalin

A useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients

Ayami Tsuchimoto, Haruka Shinke, Miwa Uesugi, Mio Kikuchi, Emina Hashimoto, Tomoko Sato, Yasuhiro Ogura, Koichiro Hata, Yasuhiro Fujimoto, Toshimi Kaido, Junji Kishimoto, Motoko Yanagita, Kazuo Matsubara, Shinji Uemoto, Satohiro Masuda

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Tacrolimus is widely used as an immunosuppressant in liver transplantation, and tacrolimus-induced acute kidney injury (AKI) is a serious complication of liver transplantation. For early detection of AKI, various urinary biomarkers such as monocyte chemotactic protein-1, liver-type fatty acid-binding protein, interleukin-18, osteopontin, cystatin C, clusterin and neutrophil gelatinase-associated lipocalin (NGAL) have been identified. Here, we attempt to identify urinary biomarkers for the early detection of tacrolimus-induced AKI in liver transplant patients. Urine samples were collected from 31 patients after living-donor liver transplantation (LDLT). Twenty recipients developed tacrolimus-induced AKI. After the initiation of tacrolimus therapy, urine samples were collected on postoperative days 7, 14, and 21. In patients who experienced AKI during postoperative day 21, additional spot urine samples were collected on postoperative days 28, 35, 42, 49, and 58. The 8 healthy volunteers, whose renal and liver functions were normal, were asked to collect their blood and spot urine samples. The urinary levels of NGAL, monocyte chemotactic protein-1 and liver-type fatty acid-binding protein were significantly higher in patients with AKI than in those without, while those of interleukin-18, osteopontin, cystatin C and clusterin did not differ between the 2 groups. The area under the receiver operating characteristics curve of urinary NGAL was 0.876 (95% confidence interval, 0.800-0.951; P<0.0001), which was better than those of the other six urinary biomarkers. In addition, the urinary levels of NGAL at postoperative day 1 (p= 0.0446) and day 7 (p=0.0006) can be a good predictive marker for tacrolimus-induced AKI within next 6 days, respectively. In conclusion, urinary NGAL is a sensitive biomarker for tacrolimus-induced AKI, and may help predict renal event caused by tacrolimus therapy in liver transplant patients.

Original languageEnglish
Article numbere110527
JournalPloS one
Volume9
Issue number10
DOIs
Publication statusPublished - Oct 20 2014

Fingerprint

tacrolimus
Lipocalins
liver transplant
Gelatinases
Transplants
Tacrolimus
Biomarkers
Acute Kidney Injury
Liver
neutrophils
biomarkers
kidneys
Urine
Liver Transplantation
urine
Clusterin
Cystatin C
Fatty Acid-Binding Proteins
Interleukin-18
Osteopontin

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)

Cite this

Urinary neutrophil gelatinase-associated lipocalin : A useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients. / Tsuchimoto, Ayami; Shinke, Haruka; Uesugi, Miwa; Kikuchi, Mio; Hashimoto, Emina; Sato, Tomoko; Ogura, Yasuhiro; Hata, Koichiro; Fujimoto, Yasuhiro; Kaido, Toshimi; Kishimoto, Junji; Yanagita, Motoko; Matsubara, Kazuo; Uemoto, Shinji; Masuda, Satohiro.

In: PloS one, Vol. 9, No. 10, e110527, 20.10.2014.

Research output: Contribution to journalArticle

Tsuchimoto, A, Shinke, H, Uesugi, M, Kikuchi, M, Hashimoto, E, Sato, T, Ogura, Y, Hata, K, Fujimoto, Y, Kaido, T, Kishimoto, J, Yanagita, M, Matsubara, K, Uemoto, S & Masuda, S 2014, 'Urinary neutrophil gelatinase-associated lipocalin: A useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients', PloS one, vol. 9, no. 10, e110527. https://doi.org/10.1371/journal.pone.0110527
Tsuchimoto, Ayami ; Shinke, Haruka ; Uesugi, Miwa ; Kikuchi, Mio ; Hashimoto, Emina ; Sato, Tomoko ; Ogura, Yasuhiro ; Hata, Koichiro ; Fujimoto, Yasuhiro ; Kaido, Toshimi ; Kishimoto, Junji ; Yanagita, Motoko ; Matsubara, Kazuo ; Uemoto, Shinji ; Masuda, Satohiro. / Urinary neutrophil gelatinase-associated lipocalin : A useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients. In: PloS one. 2014 ; Vol. 9, No. 10.
@article{a4430c8b4f5d4b3496edeebec97dde5b,
title = "Urinary neutrophil gelatinase-associated lipocalin: A useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients",
abstract = "Tacrolimus is widely used as an immunosuppressant in liver transplantation, and tacrolimus-induced acute kidney injury (AKI) is a serious complication of liver transplantation. For early detection of AKI, various urinary biomarkers such as monocyte chemotactic protein-1, liver-type fatty acid-binding protein, interleukin-18, osteopontin, cystatin C, clusterin and neutrophil gelatinase-associated lipocalin (NGAL) have been identified. Here, we attempt to identify urinary biomarkers for the early detection of tacrolimus-induced AKI in liver transplant patients. Urine samples were collected from 31 patients after living-donor liver transplantation (LDLT). Twenty recipients developed tacrolimus-induced AKI. After the initiation of tacrolimus therapy, urine samples were collected on postoperative days 7, 14, and 21. In patients who experienced AKI during postoperative day 21, additional spot urine samples were collected on postoperative days 28, 35, 42, 49, and 58. The 8 healthy volunteers, whose renal and liver functions were normal, were asked to collect their blood and spot urine samples. The urinary levels of NGAL, monocyte chemotactic protein-1 and liver-type fatty acid-binding protein were significantly higher in patients with AKI than in those without, while those of interleukin-18, osteopontin, cystatin C and clusterin did not differ between the 2 groups. The area under the receiver operating characteristics curve of urinary NGAL was 0.876 (95{\%} confidence interval, 0.800-0.951; P<0.0001), which was better than those of the other six urinary biomarkers. In addition, the urinary levels of NGAL at postoperative day 1 (p= 0.0446) and day 7 (p=0.0006) can be a good predictive marker for tacrolimus-induced AKI within next 6 days, respectively. In conclusion, urinary NGAL is a sensitive biomarker for tacrolimus-induced AKI, and may help predict renal event caused by tacrolimus therapy in liver transplant patients.",
author = "Ayami Tsuchimoto and Haruka Shinke and Miwa Uesugi and Mio Kikuchi and Emina Hashimoto and Tomoko Sato and Yasuhiro Ogura and Koichiro Hata and Yasuhiro Fujimoto and Toshimi Kaido and Junji Kishimoto and Motoko Yanagita and Kazuo Matsubara and Shinji Uemoto and Satohiro Masuda",
year = "2014",
month = "10",
day = "20",
doi = "10.1371/journal.pone.0110527",
language = "English",
volume = "9",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Urinary neutrophil gelatinase-associated lipocalin

T2 - A useful biomarker for tacrolimus-induced acute kidney injury in liver transplant patients

AU - Tsuchimoto, Ayami

AU - Shinke, Haruka

AU - Uesugi, Miwa

AU - Kikuchi, Mio

AU - Hashimoto, Emina

AU - Sato, Tomoko

AU - Ogura, Yasuhiro

AU - Hata, Koichiro

AU - Fujimoto, Yasuhiro

AU - Kaido, Toshimi

AU - Kishimoto, Junji

AU - Yanagita, Motoko

AU - Matsubara, Kazuo

AU - Uemoto, Shinji

AU - Masuda, Satohiro

PY - 2014/10/20

Y1 - 2014/10/20

N2 - Tacrolimus is widely used as an immunosuppressant in liver transplantation, and tacrolimus-induced acute kidney injury (AKI) is a serious complication of liver transplantation. For early detection of AKI, various urinary biomarkers such as monocyte chemotactic protein-1, liver-type fatty acid-binding protein, interleukin-18, osteopontin, cystatin C, clusterin and neutrophil gelatinase-associated lipocalin (NGAL) have been identified. Here, we attempt to identify urinary biomarkers for the early detection of tacrolimus-induced AKI in liver transplant patients. Urine samples were collected from 31 patients after living-donor liver transplantation (LDLT). Twenty recipients developed tacrolimus-induced AKI. After the initiation of tacrolimus therapy, urine samples were collected on postoperative days 7, 14, and 21. In patients who experienced AKI during postoperative day 21, additional spot urine samples were collected on postoperative days 28, 35, 42, 49, and 58. The 8 healthy volunteers, whose renal and liver functions were normal, were asked to collect their blood and spot urine samples. The urinary levels of NGAL, monocyte chemotactic protein-1 and liver-type fatty acid-binding protein were significantly higher in patients with AKI than in those without, while those of interleukin-18, osteopontin, cystatin C and clusterin did not differ between the 2 groups. The area under the receiver operating characteristics curve of urinary NGAL was 0.876 (95% confidence interval, 0.800-0.951; P<0.0001), which was better than those of the other six urinary biomarkers. In addition, the urinary levels of NGAL at postoperative day 1 (p= 0.0446) and day 7 (p=0.0006) can be a good predictive marker for tacrolimus-induced AKI within next 6 days, respectively. In conclusion, urinary NGAL is a sensitive biomarker for tacrolimus-induced AKI, and may help predict renal event caused by tacrolimus therapy in liver transplant patients.

AB - Tacrolimus is widely used as an immunosuppressant in liver transplantation, and tacrolimus-induced acute kidney injury (AKI) is a serious complication of liver transplantation. For early detection of AKI, various urinary biomarkers such as monocyte chemotactic protein-1, liver-type fatty acid-binding protein, interleukin-18, osteopontin, cystatin C, clusterin and neutrophil gelatinase-associated lipocalin (NGAL) have been identified. Here, we attempt to identify urinary biomarkers for the early detection of tacrolimus-induced AKI in liver transplant patients. Urine samples were collected from 31 patients after living-donor liver transplantation (LDLT). Twenty recipients developed tacrolimus-induced AKI. After the initiation of tacrolimus therapy, urine samples were collected on postoperative days 7, 14, and 21. In patients who experienced AKI during postoperative day 21, additional spot urine samples were collected on postoperative days 28, 35, 42, 49, and 58. The 8 healthy volunteers, whose renal and liver functions were normal, were asked to collect their blood and spot urine samples. The urinary levels of NGAL, monocyte chemotactic protein-1 and liver-type fatty acid-binding protein were significantly higher in patients with AKI than in those without, while those of interleukin-18, osteopontin, cystatin C and clusterin did not differ between the 2 groups. The area under the receiver operating characteristics curve of urinary NGAL was 0.876 (95% confidence interval, 0.800-0.951; P<0.0001), which was better than those of the other six urinary biomarkers. In addition, the urinary levels of NGAL at postoperative day 1 (p= 0.0446) and day 7 (p=0.0006) can be a good predictive marker for tacrolimus-induced AKI within next 6 days, respectively. In conclusion, urinary NGAL is a sensitive biomarker for tacrolimus-induced AKI, and may help predict renal event caused by tacrolimus therapy in liver transplant patients.

UR - http://www.scopus.com/inward/record.url?scp=84908220466&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908220466&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0110527

DO - 10.1371/journal.pone.0110527

M3 - Article

VL - 9

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e110527

ER -